Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
The Journal of Organic Chemistry|December 13, 1996
Photoinduced Electron Transfer Reactions of alpha-Cyclopropyl- and alpha-Epoxy Ketones. Tandem Fragmentation-Cyclization to Bi-, Tri-, and Spirocyclic KetonesThorsten Kirschberg, Jochen MattayCurrent Opinion in Drug Discovery & Development|July 31, 2007
Metal chelators as antiviral agentsThorsten Kirschberg, Jay ParrishThe Journal of Organic Chemistry|June 17, 2006
Use of benzofuran for concomitant protection of aldehyde and phenol groups in the preparation of mycophenolic acid analoguesMaria Fardis, Michael Mertzman, William Thomas, et al.Plos One|April 10, 2015
Direct binding of ledipasvir to HCV NS5A: mechanism of resistance to an HCV antiviral agentHyock Joo Kwon, Weimei Xing, Katie Chan, et al.Plos One|August 16, 2017
Biochemical characterization of recombinant influenza A polymerase heterotrimer complex: Endonuclease activity and evaluation of inhibitorsWeimei Xing, Ona Barauskas, Thorsten Kirschberg, et al.Bioorganic & Medicinal Chemistry Letters|June 8, 2014
Preparation and biological evaluation of 1'-cyano-2'-C-methyl pyrimidine nucleosides as HCV NS5B polymerase inhibitorsMichael R Mish, Aesop Cho, Thorsten Kirschberg, et al.Antimicrobial Agents and Chemotherapy|June 6, 2018
Nucleotide Prodrug Containing a Nonproteinogenic Amino Acid To Improve Oral Delivery of a Hepatitis C Virus TreatmentJoy Y Feng, Ting Wang, Yeojin Park, et al.Bioorganic & Medicinal Chemistry Letters|April 20, 2006
Phosphonic acid-containing analogues of mycophenolic acid as inhibitors of IMPDHWilliam J Watkins, James M Chen, Aesop Cho, et al.Journal of Medicinal Chemistry|December 11, 2013
Discovery of ledipasvir (GS-5885): a potent, once-daily oral NS5A inhibitor for the treatment of hepatitis C virus infectionJohn O Link, James G Taylor, Lianhong Xu, et al.Pageof 1